Pleurodesis

Subscribe to Selected New Research on Pleurodesis

827 relevant articles (90 outcomes, 82 trials/studies) found for this Therapy

Description: The production of adhesions between the parietal and visceral pleura. The procedure is used in the treatment of bronchopleural fistulas, malignant pleural effusions, and pneumothorax and often involves instillation of chemicals or other agents into the pleural space causing, in effect, a pleuritis that seals the air leak. (From Fishman, Pulmonary Diseases, 2d ed, p2233 & Dorland, 27th ed)

Relationship Network

Therapy Context: Research Results

Therapeutics: 5215

Drug Therapy: 116820

Pleurodesis: 827

Experts

1.	Lee, Y C Gary: 4 articles (07/2008 - 12/2003)
2.	Davies, Robert J O: 4 articles (07/2008 - 12/2003)
3.	Light, Richard W: 3 articles (08/2005 - 08/2002)
4.	Maskell, Nick A: 3 articles (07/2005 - 12/2003)
5.	Milton, Richard: 2 articles (12/2007 - 11/2003)
6.	Vargas, Francisco S: 2 articles (10/2007 - 08/2005)
7.	Marchi, Evaldo: 2 articles (10/2007 - 08/2005)
8.	Aelony, Yossef: 2 articles (05/2007 - 10/2006)
9.	Loddenkemper, Robert: 2 articles (05/2007 - 11/2004)
10.	Tamm, M: 2 articles (04/2007 - 10/2000)

Related Diseases

1.	Pneumothorax 01/01/2000 - "CONCLUSIONS: VATS combined with mechanical brush pleurodesis using the electrical brush system is a highly effective and safe treatment for patients with recurrent primary spontaneous pneumothorax." 09/01/2007 - "Spontaneous pneumothorax is a common problem and in patients at risk of recurrence, excision of the source of the air leak and pleurodesis is very effective in reducing further episodes" 01/01/1988 - "We conclude that thoracoscopy enables accurate assessment of the type of pneumothorax, and can play an important role in the management of SP. Chemical pleurodesis causes a significant reduction of the recurrence rate in the treatment of idiopathic SP." 06/01/2007 - "He was treated successfully with surgery to the left pneumothorax that had been refractory to conservative chest tube drainage and chemical pleurodesis" 02/01/2004 - "We describe an 8-year-old boy with acute lymphoblastic leukaemia complicated by chronic GVHD-related BO, and subsequent pneumothorax with persistent air leak, who was treated successfully with autologous blood pleurodesis." Order ALL the reference details at left...
2.	Malignant Pleural Effusion 06/01/2003 - "CONCLUSIONS: Chemical pleurodesis can be accomplished with good results in < 24 h in the majority of patients with malignant pleural effusions." 11/01/1997 - "In conclusion, VATS has provided a high positive diagnosis of patients with malignant pleural effusions not diagnosed by conventional methods and good results in pleurodesis, but some operating skills must be emphasized." 10/01/2007 - "Tunnelled pleural catheters are an effective way of controlling malignant pleural effusions when used as first-line treatment in patients who appear to be candidates for pleurodesis procedures." 03/26/1999 - "Effective treatment of malignant pleural effusion: Thoracoscopic talcum pleurodesis and pleuro-peritoneal shunt]" 01/01/1998 - "Chemical pleurodesis is an effective treatment of malignant pleural effusions, but indications must be individualised to optimise its results" Order ALL the reference details at left...
3.	Pleural Effusion (Pleural Effusions) 04/01/2002 - "Accordingly, pleurodesis with minocyclin was undertaken, which was fortunately effective for controlling the pleural effusion." 03/01/2007 - "OBJECTIVE: To assess whether intractable pleural effusions in pediatric oncology patients at end of life could be sufficiently relieved by pleurodesis" 11/01/2006 - "Overall, this review supports the safety and efficacy of iodopovidone as an agent for chemical pleurodesis in cases of recurrent pleural effusions and pneumothoraces regardless of their etiology." 05/01/2001 - "We also propose that the prognosis of patients with refractory pleural effusion receiving long-term hemodialysis would be improved by early pleurodesis." 11/01/2004 - "STUDY OBJECTIVES: Patients with recurrent pleural effusions secondary to malignancy are subjected to pleurodesis if clinically indicated" Order ALL the reference details at left...
4.	Adhesions 05/01/2004 - "At 3 weeks, all animals were sacrificed and efficacy of pleurodesis was macroscopically assessed by three independent reviewers blinded to the treatment of animals using a five-point severity pleurodesis score (from 0, no adhesions to 4, complete symphisis) and obliteration grade rating the distribution of adhesions (from 0, no adhesions to 4, adhesions in the whole chest)" 02/01/1993 - "At evaluation at 30 +/- 2 days, the efficacy of pleurodesis was graded on a scale of 0 to 4, with 0 representing a complete absence of pleural symphysis and 4 the adhesion of more than one lobe to both the chest wall and mediastinum" 02/01/1997 - "At autopsy, the efficacy of pleurodesis was graded by evaluating the gross appearance of each pleural cavity and lung (pleurodesis score), and by determining the extent of adhesion formation (obliteration grade)" 06/01/2008 - "The rabbits were euthanatized 30 days after the operation to determine pleurodesis score, area of greatest adhesion, thoracic volume change, and histopathological findings" 01/01/2008 - "The patient did not request pleurodesis, because pleural adhesions might impair pulmonary function" Order ALL the reference details at left...
5.	Hydrothorax 05/27/2006 - "Pleurodesis was effective in the woman while in the remaining man hepatic hydrothorax was only a temporary, asymptomatic finding" 10/01/2003 - "Acute hydrothorax in a peritoneal dialysis patient: long-term efficacy of autologous blood cell pleurodesis associated with small-volume peritoneal exchanges." 09/01/2004 - "Although the cause of recurrent hydrothorax is unknown, it may be that not only surgical repair but also more intense pleurodesis is needed." 01/01/2004 - "CONCLUSION: Our new technique of thoracoscopic pleurodesis is an effective and minimally invasive treatment for patients with refractory hepatic hydrothorax." 01/01/2004 - "A new technique of thoracoscopic pleurodesis for refractory hepatic hydrothorax." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Talc
2.	Tetracycline (Achromycin)
3.	Picibanil
4.	Bleomycin (Blenoxane)
5.	Doxycycline (Vibramycin)
6.	Fibrin Tissue Adhesive (Fibrin Sealant)
7.	Minocycline (Cyclops)
8.	polidocanol (Laureth)
9.	thymidine 5'-triphosphate (TTP)
10.	Sclerosing Solutions (Sclerosing Agents)

Related Therapies and Procedures

1.	Thoracostomy
2.	Chest Tubes (Chest Tube)
3.	Ligation
4.	Peritoneal Dialysis
5.	Sclerotherapy

Best Treatments:
Research Summary Report
on Pneumothorax

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 108 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>